+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Negative Pressure Wound Therapy Market Size, Share & Trends Analysis Report By End-Use, By Product, By Type (Pressure Ulcers, Diabetic Foot Ulcers, Venous Leg Ulcers, Burn Wounds, and Others), By Country and Growth Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 103 Pages
  • January 2024
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5928484
The Europe Negative Pressure Wound Therapy Market would witness market growth of 6.2% CAGR during the forecast period (2023-2030).

Technological advancements in NPWT devices have played a pivotal role in their adoption. Portable and user-friendly devices have made it feasible for NPWT to be administered in hospital settings and home healthcare environments. The development of compact, battery-operated devices has enhanced the flexibility of the NPWT application, contributing to its increased adoption. The inclusion of NPWT in clinical practice guidelines and recommendations by reputable healthcare organizations has further legitimized its adoption.

Ongoing educational initiatives aimed at healthcare professionals have driven NPWT adoption. Training programs, workshops, and educational materials help disseminate knowledge about the benefits and proper use of NPWT, fostering confidence among healthcare providers in incorporating this therapy into their practice. The growing number of people with chronic wounds, such as pressure sores and diabetic ulcers, has increased the demand for efficient wound care solutions. NPWT's success in managing these challenging conditions has led to its widespread adoption as a primary modality for treating chronic wounds.

As per the UK government’s report named “Future of an aging population,” by 2040, nearly one in seven people is projected to be over 75. By 2037, there are projected to be 1.42 million more households headed by someone aged 85 or over, an increase of 161% over 25 years. The overall increase in life expectancy in the UK contributes to a larger population of older adults. The growing preference for home healthcare among seniors creates an opportunity for NPWT devices designed for use outside traditional healthcare settings in the UK. As healthcare standards evolve in the UK, there is an increased emphasis on evidence-based practices and advanced wound care solutions. Hence, all these factors will uplift the regional market’s expansion in the coming years.

The Germany market dominated the Europe Negative Pressure Wound Therapy Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $244.5 million by 2030. The UK market is exhibiting a CAGR of 5.2% during (2023 - 2030). Additionally, The France market would experience a CAGR of 7% during (2023 - 2030).

Based on End-Use, the market is segmented into Hospitals, Homecare, and Others. Based on Product, the market is segmented into Conventional NPWT, and Single-use NPWT. Based on Type, the market is segmented into Pressure Ulcers, Diabetic Foot Ulcers, Venous Leg Ulcers, Burn Wounds, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

  • 3M Company
  • Talley Group Ltd. (Direct Healthcare Group)
  • Smith & Nephew PLC
  • Molnlycke Health Care AB
  • DeRoyal Industries, Inc.
  • ConvaTec Group PLC
  • Cardinal Health, Inc.
  • HARTMANN Group (Paul Hartmann AG)
  • Cork Medical, LLC

Market Report Segmentation

By End-Use
  • Hospitals
  • Homecare
  • Others
By Product
  • Conventional NPWT
  • Single-use NPWT
By Type
  • Pressure Ulcers
  • Diabetic Foot Ulcers
  • Venous Leg Ulcers
  • Burn Wounds
  • Others
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Negative Pressure Wound Therapy Market, by End-Use
1.4.2 Europe Negative Pressure Wound Therapy Market, by Product
1.4.3 Europe Negative Pressure Wound Therapy Market, by Type
1.4.4 Europe Negative Pressure Wound Therapy Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Europe Negative Pressure Wound Therapy Market, By End-Use
4.1 Europe Hospitals Market, By Country
4.2 Europe Homecare Market, By Country
4.3 Europe Others Market, By Country
Chapter 5. Europe Negative Pressure Wound Therapy Market, By Product
5.1 Europe Conventional NPWT Market, By Country
5.2 Europe Single-use NPWT Market, By Country
Chapter 6. Europe Negative Pressure Wound Therapy Market, By Type
6.1 Europe Pressure Ulcers Market, By Country
6.2 Europe Diabetic Foot Ulcers Market, By Country
6.3 Europe Venous Leg Ulcers Market, By Country
6.4 Europe Burn Wounds Market, By Country
6.5 Europe Others Market, By Country
Chapter 7. Europe Negative Pressure Wound Therapy Market, By Country
7.1 Germany Negative Pressure Wound Therapy Market
7.1.1 Germany Negative Pressure Wound Therapy Market, By End-Use
7.1.2 Germany Negative Pressure Wound Therapy Market, By Product
7.1.3 Germany Negative Pressure Wound Therapy Market, By Type
7.2 UK Negative Pressure Wound Therapy Market
7.2.1 UK Negative Pressure Wound Therapy Market, By End-Use
7.2.2 UK Negative Pressure Wound Therapy Market, By Product
7.2.3 UK Negative Pressure Wound Therapy Market, By Type
7.3 France Negative Pressure Wound Therapy Market
7.3.1 France Negative Pressure Wound Therapy Market, By End-Use
7.3.2 France Negative Pressure Wound Therapy Market, By Product
7.3.3 France Negative Pressure Wound Therapy Market, By Type
7.4 Russia Negative Pressure Wound Therapy Market
7.4.1 Russia Negative Pressure Wound Therapy Market, By End-Use
7.4.2 Russia Negative Pressure Wound Therapy Market, By Product
7.4.3 Russia Negative Pressure Wound Therapy Market, By Type
7.5 Spain Negative Pressure Wound Therapy Market
7.5.1 Spain Negative Pressure Wound Therapy Market, By End-Use
7.5.2 Spain Negative Pressure Wound Therapy Market, By Product
7.5.3 Spain Negative Pressure Wound Therapy Market, By Type
7.6 Italy Negative Pressure Wound Therapy Market
7.6.1 Italy Negative Pressure Wound Therapy Market, By End-Use
7.6.2 Italy Negative Pressure Wound Therapy Market, By Product
7.6.3 Italy Negative Pressure Wound Therapy Market, By Type
7.7 Rest of Europe Negative Pressure Wound Therapy Market
7.7.1 Rest of Europe Negative Pressure Wound Therapy Market, By End-Use
7.7.2 Rest of Europe Negative Pressure Wound Therapy Market, By Product
7.7.3 Rest of Europe Negative Pressure Wound Therapy Market, By Type
Chapter 8. Company Profiles
8.1 DeRoyal Industries, Inc.
8.1.1 Company Overview
8.2 Cork Medical, LLC
8.2.1 Company Overview
8.2.2 Recent strategies and developments:
8.2.2.1 Product Launches and Product Expansions:
8.3 3M Company
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.3.5.2 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 Talley Group Ltd. (Direct Healthcare Group)
8.4.1 Company Overview
8.5 Smith & Nephew PLC
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional and Segmental Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.5.6 SWOT Analysis
8.6 Molnlycke Health Care AB
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Product Launches and Product Expansions:
8.6.3 SWOT Analysis
8.7 ConvaTec Group PLC
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 SWOT Analysis
8.8 Cardinal Health, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 SWOT Analysis
8.9 HARTMANN Group (Paul Hartmann AG)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Acquisition and Mergers:
8.9.6 SWOT Analysis

Companies Mentioned

  • 3M Company
  • Talley Group Ltd. (Direct Healthcare Group)
  • Smith & Nephew PLC
  • Molnlycke Health Care AB
  • DeRoyal Industries, Inc.
  • ConvaTec Group PLC
  • Cardinal Health, Inc.
  • HARTMANN Group (Paul Hartmann AG)
  • Cork Medical, LLC

Methodology

Loading
LOADING...